Showing 8331-8340 of 8647 results for "".
- First Patient Successfully Implanted with Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoringhttps://modernod.com/news/first-patient-successfully-implanted-with-implandatas-eye-pressure-sensor-for-continual-glaucoma-monitoring/2476170/Ophthalmic medical device company Implandata Ophthalmic Products announced that the first patient in its international, multicenter, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the supr
- Envision Conference to Split in Two in 2019https://modernod.com/news/envision-conference-to-split-in-two-in-2019/2479634/For the first time since its inception in 2006, Envision Conference will be split into two events for the upcoming year: Envision Conference East, March 22-23, 2019 at the University of Alabama at Birmingham in Birmingham, Alabama; and Envision Conference West, October 5-6, 2019 at the College of
- Lynx Inventory System Now Customized for Retina Specialistshttps://modernod.com/news/lynx-inventory-system-now-customized-for-retina-specialists/2479638/McKesson announced that Lynx, its customizable, cloud-based medication inventory management system for specialty medical practices, has new features designed especially for delivering injectable medication therapies in retina practices. These customizations for retina specialists ensure that each
- Glaucoma-Staging Systems May Underestimate Severityhttps://modernod.com/news/glaucoma-staging-systems-may-underestimate-severity/2479639/Standard automated perimetry (SAP) testing is often used to classify glaucoma severity but may fail to detect macular damage, according to New York City-based researchers, as reported in Reuters. “Because current staging syst
- SECO 2019 Puts Spotlight On Vision Industry Trendshttps://modernod.com/news/seco-2019-puts-spotlight-on-vision-industry-trends/2479643/SECO 2019 will lead the conversation on the latest vision industry trends when SECO 2019 takes place February 20-24, 2019 in New Orleans. From the latest technological innovations in eye and healthcare to up-and-coming eyewear products, SECO 2019 is where the optometric community of professional
- Interface Biologics Completes Pre-IND Meeting with FDA on Epidel Technology for Treatment of Posterior Inflammatory Eye Diseaseshttps://modernod.com/news/interface-biologics-completes-pre-ind-meeting-with-fda-on-epidel-technology-for-treatment-of-posterior-inflammatory-eye-diseases/2479645/Interface Biologics has announced a positive pre-investigational new drug meeting with the FDA for its dexamethasone intravitreal implant for the treatment of posterior inflammatory eye diseases. The FDA concurred with IBI’s manufacturing and clinical development plans, based on the precl
- Eyenovia Initiates Phase 3 MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Studyhttps://modernod.com/news/eyenovia-initiates-phase-3-microstat-program-for-pharmacologic-mydriasis-enrolls-first-patient-in-mist-1-study/2479648/Eyenovia announced that it has enrolled the first patient in the first of two phase 3 trials (MIST-1 and MIST-2) of the company’s MicroStat program for pharmacologic mydriasis. The studies will investigate the safety and efficacy of the company’s first-in-class fixed-combination p
- FDA Revamping Clearance Procedures for Medical Deviceshttps://modernod.com/news/fda-revamping-clearance-procedures-for-medical-devices/2479649/The FDA is significantly revamping the way it clears most medical devices for U.S. marketing, planning to rely far less on comparisons with much older products already on the market, according to a
- Takeda Gains Clearance from European Commission for Shire Purchasehttps://modernod.com/news/takeda-gains-clearance-from-european-commission-for-shire-purchase/2479653/Takeda announced Tuesday that it received clearance from the European Commission for its proposed $62-billion acquisition of Shire, with the condition that Takeda sells its experimental anti-integrin agent SHP647 and certain associated rights. Takeda said it expects SHP647 “to attract inter
- Santen Expands Research and Development Leadership Teamhttps://modernod.com/news/santen-expands-research-and-development-leadership-team/2479666/Santen announced the expansion of its research and development leadership team through the addition of two new executive hires. Reza M. Haque, MD, PhD, has been appointed as Senior Vice President, Global Research and Development Strategy, and Peter Sallstig, MD, MBA